Synapse - Sarcoma Service (Pediatrics)

Search Within

Sarcoma Service (Pediatrics)

Results (614)

Irinotecan for pediatric solid tumors: The Memorial Sloan-Kettering experience

Journal Article

Cosetti, M.; Wexler, L. H.; Calleja, E.; Trippett, T.; Laquaglia, M.; Huvos, A. G.; Gerald, W.; Healey, J. H.; Meyers, P. A.; Gorlick, R.
Journal of Pediatric Hematology/Oncology (2002)

Fulltext@MSK | Save

Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center experience

Journal Article

Aung, L.; Gorlick, R. G.; Shi, W.; Thaler, H.; Shorter, N. A.; Healey, J. H.; Huvos, A. G.; Meyers, P. A.
Cancer (2002)

Fulltext@MSK | Save

Mutations/polymorphrisms in the reduced folate carrier(RFC) are observed frequently in osteosarcoma tumor samples

Meeting Abstract

Yang, R.; Mazza, B.; Sowers, R.; Healey, J.; Huvos, A.; Bertino, J. R.; Meyers, P.; Gorlick, Richard
Proceedings of the American Association for Cancer Research Annual Meeting (2001)

Fulltext@MSK | Save

Functional impairments in methotrexate transport are common in osteosarcoma tumor samples

Meeting Abstract

Mazza, B. D.; Meyers, P. A.; Sowers, R. S.; Huvos, A. G.; Healey, J. H.; Bertino, J. R.; Koutcher, J.; Gorlick, R.
Proceedings of the American Association for Cancer Research Annual Meeting (2001)

Fulltext@MSK | Save

Co-deletion of methylthioadenosine phosphorylase (MTAP) and p15INK4b/p16INK4a in osteosarcoma (OS) and its impact on chemosensitivity

Meeting Abstract

Garcia-Castellano, J. M.; Villanueva, A.; Jung, C.; Healey, J. H.; Huvos, A.; Bertino, J.; Tan, C.; Meyers, P.; Gorlick, R.
Proceedings of the American Association for Cancer Research Annual Meeting (2001)

Fulltext@MSK | Save

Irinotecan (CPT-11) may be an active agent in the treatment of pediatric rhabdomyosarcoma: The Memorial Hospital experience

Meeting Abstract

Cosetti, M. K.; Gorlick, R.; Meyers, P.; Wexler, L.; Calleja, E.; Trippett, T.; Laquaglia, M.; Healey, J.; Huvos, A.
Pediatric Research (2001)

Fulltext@MSK | Save

Sublocalization of LOH18CR, a tumor suppressor gene implicated in osteosarcoma, to a minimal region between D18S87 and D18S42

Meeting Abstract

Nellissery, M. J.; Johnson-Pais, T. L.; Buller, C.; Bhatia, P.; Ammerman, D. G.; Deshpande, A. M.; Pathmanathan, D.; Benjamin, R. S.; Gorlick, R.; Meyers, P. A.; more...
American Journal of Human Genetics (2001)

Fulltext@MSK | Save

Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma

Journal Article

Morris, C. D.; Gorlick, R.; Huvos, A. G.; Heller, G.; Meyers, P. A.; Healey, J. H.
Clinical Orthopaedics and Related Research (2001)

Fulltext@MSK | Save

How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review

Journal Article

Kushner, B. H.; Meyers, P. A.
Journal of Clinical Oncology (2001)

Fulltext@MSK | Save

High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis

Journal Article

Meyers, P. A.; Krailo, M. D.; Ladanyi, M.; Chan, K. W.; Sailer, S. L.; Dickman, P. S.; Baker, D. L.; Davis, J. H.; Gerbing, R. B.; Grovas, A.; more...
Journal of Clinical Oncology (2001)

Fulltext@MSK | Save